To evaluate the effect of alendronate on the occurrence rate of multiple svmptomatic fractures and on the risk of multiple symptomatic fractures (likelihood of having more than one fracture diagnosed because of the symptoms the fractures caused over the study period) among women with osteoporosis.
Department of Medicine, Osteoporosis Center, University of Miami School of Medicine, 1475 Northwest 12 Avenue, Suite 407, Miami, FL 33101, USA. slevis@med.miami.edu